Homer Adams III

Homer Adams III, Ph.D., is a seasoned leader in translational medicine with extensive experience in full clinical product development. Currently serving as Director at Genmab since May 2020, Homer drives scientific strategy and manages international collaborations to optimize product differentiation and project management. Prior roles include Associate Director at both Genmab and The Janssen Pharmaceutical Companies of Johnson & Johnson, where responsibility for biomarker lead in hematological malignancy compounds and co-leading pediatric pre-clinical teams was key. Homer's academic background includes a Ph.D. in Cancer Genetics from Rutgers University - Newark, and a history of successful mentoring, program development, and fundraising in various research settings.